United States · FDA National Drug Code directory
Ropivacaine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65219-632_7203f32f-2e48-4924-b882-d4f3863ae952
- Product NDC
- 65219-632
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Ropivacaine Hydrochloride
- Labeler
- FRESENIUS KABI USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241210
- Source listing expiry
- 20261231
Source-listed ingredients
- ROPIVACAINE HYDROCHLORIDE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 24 BAG in 1 CASE (65219-632-10) / 100 mL in 1 BAG (65219-632-02) · 65219-632-10
- 24 BAG in 1 CASE (65219-632-20) / 200 mL in 1 BAG (65219-632-04) · 65219-632-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →